US OptionsDetailed Quotes
VKTX241129P70000
- 16.16
- 0.000.00%
15min DelayClose Nov 27 16:00 ET
0.00High0.00Low
16.16Open16.16Pre Close0 Volume9 Open Interest70.00Strike Price0.00Turnover224.74%IV1.23%PremiumNov 29, 2024Expiry Date15.49Intrinsic Value100Multiplier2DDays to Expiry0.67Extrinsic Value100Contract SizeAmericanOptions Type-0.9471Delta0.0135Gamma3.48Leverage Ratio-0.1582Theta-0.0024Rho-3.30Eff Leverage0.0039Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet